Nigeria receives HIV prevention injection
The Federal Government on Wednesday confirmed the receipt of the HIV prevention injection known as Lenacapavir.
National coordinator of the National HIV, viral hepatitis and STDs control programme at the Federal Ministry of Health and Social Welfare, Dr Adebobola Bashorun, in a statement on Wednesday, said the arrival of LEN reflects Nigeria’s continued dedication to leveraging innovation and evidence-based interventions to accelerate progress toward epidemic control.
Bashorun said, “NASCP, in collaboration with partners and stakeholders, will work to ensure the safe introduction, strategic deployment, and effective integration of Lenacapavir into the national HIV prevention options.
“The rollout will support ongoing efforts to increase access to prevention services while reinforcing Nigeria’s broader HIV response.
NASCP remains committed to advancing equitable access to HIV prevention, testing, treatment, and care services. The arrival of Long-Acting Injectable Lenacapavir is a clear demonstration of Nigeria’s resolve to scale up innovative solutions and strengthen the fight against HIV. Together, Nigeria moves closer to ending HIV as a public health threat.”
Lenacapavir is an injectable treatment administered twice yearly, offering a more convenient alternative to daily oral preventive medications.
The statement noted that the introduction of Lenacapavir for PrEP marks a significant step towards broadening the range of prevention choices available to individuals at risk of HIV infection.
